• 

  Salem's academic promotion fee was once named by the regulator, and the chief scientist resigned in January after listing

  2023-08-01 15:32
• 

  Under the medical anti-corruption, the boss of Salem Biology was investigated, and the medical shares fell sharply

  2023-07-31 15:11
• 

  Abandoned the "Randy Calcium" bet on hair loss, Zhendong Pharmaceutical still lost 1.9 billion yuan in marketing

  2023-07-27 12:12
• 

  Behind the "monkey hoarding" of Zhaoyan New Drug: the shareholders have realized 4.5 billion yuan

  2023-07-21 10:22
• 

  After the pains of centralized purchasing, Ganli Pharmaceutical can't catch up with Tonghua Dongbao?

  2023-07-18 19:31
• 

  Baekje China was "Charged" by Novartis: $3 billion income changed to $300 million

  2023-07-12 15:16
• 

  Pharmaceutical companies hunting for Lilalutide: Hanyu Pharmaceutical's withdrawal to East China Pharmaceutical was approved

  2023-07-06 18:05
• 

  Policies and regulations of Hanyu Pharmaceutical? Lilalutide was listed, abandoning China Baomei

  2023-07-03 18:12
• 

  36 million yuan was thrown away for nothing. Step Pharma sold its assets for 1 yuan and cut off whose leeks?

  2023-06-29 17:52
• 

  Qiming Medical Mystery: After executives borrowed heavily, CFO resigned

  2023-06-09 09:54
• 

  Novo Nordisk and East China Medicine vie for the first place on the list of "the best medicine for losing weight"

  2023-06-06 17:05
• 

  The price of contraceptives is monopolized, and China Resources' companies are subject to antitrust punishment

  2023-05-31 18:50
• 

  After the completion of the new crown, Yuekang Pharmaceutical, which sells Viagra, opens the clinical application of the new crown medicine

  2023-05-12 13:38
• 

  Zhejiang Medicine's Strange Fact: 60 million yuan of unsolicited transfer from its drugstore

  2023-05-10 14:03

• Net profit of Beida Pharmaceutical dropped sharply: the price of the first domestic anti-cancer drug fell due to medical insurance

  2023-04-26 09:54
• 

  Lianhua Qingwen's market share has shrunk slightly, and it is still difficult to register in the United States for 8 years

  2023-04-26 09:51

• The first quarter's revenue and net profit stopped falling and rebounded, and Hengrui Pharmaceutical is now at a turning point?

  2023-04-21 21:53
• 

  In the fifth year of A-share listing, WuXi AppTec shareholders reduced their holdings for the 91st time

  2023-04-18 14:30

• Without the new crown test, Dean Diagnostics' net profit in the first quarter fell by 70%

  2023-04-18 13:04
• 

  Accounting for 40% of the revenue, Dean Diagnostics' revenue of 8 billion New Crown Nucleic Acid became the swan song

  2023-04-13 16:20

• See again life-saving medicine is monopolized! Tianjin Pharmaceutical was fined more than 100 million yuan three times in two years

  2023-04-12 18:33

• IPO of Haisen Pharmaceutical: undisclosed contaminated groundwater under supervision

  2023-03-29 11:34

• WuXi AppTec lost nearly 1.2 billion yuan in stock trading last year, and the research and development of new drugs in China shrank

  2023-03-22 15:56

• After the highlight of New Crown Vaccine, the profit of Zhifei Biology fell by nearly 2.7 billion

  2023-03-21 13:15

• The brake of Tibet Pharmaceutical Xinguan Vaccine Project: 7 billion hits of water

  2023-03-17 11:42

• Hengrui Medicine 200 million quilt cover: investment in new anti-cancer drugs has not been approved in China and the United States

  2023-03-14 16:39

• Baekje China is trapped in Silicon Valley Bank with more than 170 million dollars

  2023-03-13 15:12

• After the meeting, the trademark infringement dispute continued: the case has been filed

  2023-03-09 21:04

• Behind being pursued by Tongce Medical: Heren Technology's financial report and Tibet mystery

  2023-02-28 16:12

• Former ATV boss returns to real estate after cross-border failure: medical valuation collapse

  2023-02-21 13:24

• Nuocheng Jianhua's "Black Swan": Innovative drugs entering medical insurance are abandoned overseas

  2023-02-16 13:08

• The daughter of Rongsheng Biological's actual controller acts as the proxy: Xiao, who took bribes of 125 million yuan, once became a shareholder

  2023-02-15 14:42

• New Crown Vaccine failed to sell, with an expected loss of more than 800 million, and Concino returned to the loss

  2023-01-31 16:18

• Cash out immediately after the expiration of the ban, Fosun plans to liquidate its holdings in Huakang Medical

  2023-01-31 16:16

• New Crown Oral Drug Is Approved to Turn into Likong? Junshi Biology Welcomes the First Fall of the Year of the Rabbit

  2023-01-30 17:14

• Pioneer Pharmaceuticals Xinguan Oral Medicine: first come into the market and then publish clinical data

  2023-01-17 18:17

• Jingjie Biological IPO: Lv Songtao's new gamble in Green Valley?

  2023-01-12 10:32

• Great loss of Kangtai Biology: the unsold new crown vaccine lost all profits

  2023-01-11 13:10

• The huge loss of Guangshengtang soared, saying that the efficacy of the new crown drug under research was better than Pfizer P

  2023-01-10 17:35

• Aier Ophthalmology Department was fined more than 30 times last year, with most medical insurance and advertising violations

  2023-01-09 15:28

• The blood oximeter rose from 94 yuan to 299 yuan, and Yuyue Medical staged a show of shaking the pot | company report series VOL.051

  2023-01-04 17:17

• Problem of Yiling Pharmaceutical: Lianhua Qingwen Capsule is difficult to register in the United States for 7 years

  2022-12-22 18:47

• Feiyu Technology IPO: Fuxiang Pharmaceutical Bao Jianhua One Fish, Two Meals

  2022-12-21 16:58

• Hendy Pharmaceuticals plummeted 13% after the Ibuprofen craze

  2022-12-20 20:57

• Nuokonda IPO: shareholders who can't return, gambles that can't be completed

  2022-12-16 13:58

• Electronic drug injection pen of Huayang Shares: How much did Jinsai Pharmaceutical buy?

  2022-12-13 14:08

• 12 clarifications were ignored, and Xinhua Pharmaceutical was hyped with its new concept

  2022-12-13 09:51

• The crazy Lianhua Qingwen mask came out

  2022-12-07 11:44

• Li Jiexun IPO: promotion service providers gather to hide secrets

  2022-12-07 10:38

• Several new coronal vaccines are included in emergency use in clinical stage

  2022-12-05 17:15

• Hengrui Pharmaceutical executives quit: the new chief medical executive resigned

  2022-12-05 16:50

• Hengrui Pharmaceuticals made a bet of 100 million yuan on new anti-cancer drugs, bogged down in clinical value

  2022-12-01 15:14

• Behind the 800 million promotion fee of Suilu Cross: multiple service providers have relevance

  2022-11-30 13:10

• File a case for investigation! Family enterprise Haooubo Real controller ATM

  2022-11-29 15:44

• Domestic Xinguan oral medicine is in fierce competition, and Sinovac is catching up to open Phase II clinical

  2022-11-24 18:53

• Batch resignation of senior executives of Nuotai Biology: the face of pillar subsidiaries changed

  2022-11-23 13:54

• IPO of Yipin Pharmaceutical: Market Promoters Are Confused

  2022-11-22 11:27

• New Crown concept magic pharmacy 6 boards, OEM pharmaceutical enterprise cooperation Zhong Nanshan

  2022-11-17 17:17

• Bribery bill of Anesthesiology Department of a Grade III A hospital

  2022-11-17 13:37

• IPO of Yisheng Biology: 0 new major customers

  2022-11-16 19:33

• Keruide IPO: False invoice, service provider is Phantom Company

  2022-11-15 10:35

• Nuocheng Jianhua continued to lose money from January to September, and Shi Yigong's family was worth 3.8 billion

  2022-11-14 16:01

• Wangao Pharmaceutical's IPO: three times of breakthrough and chaos of related party transactions

  2022-11-11 09:46

• IPO of Xuanzhu Biology: the original shareholder dumped 1.1 billion yuan of losses to shareholders

  2022-11-09 15:32

• Kechuangbang Warner Pharmaceutical Co., Ltd.: Another 30 million yuan was claimed for patent infringement

  2022-11-09 11:28

• IPO of Zhonghan Biology: How long can the story of Xinguan Test Reagent last?

  2022-11-08 15:25

• Weiming Medicine Loses the First Round: Strive for Kexing Biotech to lose 15.4 million yuan in advance

  2022-11-07 12:19

• Zhixiang Jintai IPO: loss of 800 million yuan in three years, 90% of revenue from related transactions

  2022-11-04 10:59

• IPO of Rongsheng Biology: single product, profitability becomes a problem

  2022-11-03 10:42

• Ping An, a good doctor who lost 6 billion yuan, started to take the slide without profit

  2022-11-02 11:44

• Angels IPO: Can ponies pull big cars?

  2022-11-02 11:43

• Partner drag, Fosun Pharmaceutical's net profit in the third quarter fell 16.2% year on year

  2022-10-30 22:11

• Third quarter report of Zhifei Biology: no profit increase due to income increase, and no new vaccine is proposed

  2022-10-28 12:26

• WuXi AppTec's performance blowout in the third quarter, too much money to cancel overseas additional issuance

  2022-10-26 21:49

• Watson Biological Q3: Vaccine sales soared, and the stock market lost 170 million yuan

  2022-10-26 15:01

• Tongce Medical's performance in the third quarter fell sharply: insufficient consumption willingness

  2022-10-25 14:21

• The Third Quarterly Report of Thunderstorm Hits the Limit of Decline; Pien Tze huang: Accounts Receivable Continues to Be High

  2022-10-24 17:09

• Core technology weakness? Jiachuang Biological Stop Growth Enterprise Market

  2022-10-14 11:13

• Zhifei Biological HPV Vaccine Bribery

  2022-10-12 07:24

• 500 year old Tai'antang was disabled by playing: wearing hats, ST continued to decline

  2022-09-29 16:19

• IPO of Huadao Shares: customer authenticity is questionable

  2022-09-23 13:53

• Insider trading of the former chairman of Hengrui Pharmaceutical with an annual salary of 10 million yuan: profit of 450000 yuan

  2022-09-21 13:17

• Prohibited pesticide residue of chrysanthemum, Zhejiang Zhenyuan subsidiary was investigated

  2022-09-19 13:15

• Truth about the IPO of Shuohua Life: the largest customer has been dissolved

  2022-09-14 18:59

• The United States launched a new biotechnology law, and pharmaceutical R&D concept stocks fell sharply

  2022-09-13 13:46

• Putian tycoons win miserably in Guangzheng Ophthalmology Department: 200 million less by selling shells

  2022-09-07 15:46

• Fosun Pharmaceuticals "just a drop in the bucket": reducing 80 million shares and increasing 460000 shares

  2022-09-06 23:25

• Guo Guangchang plans to reduce his holdings by more than 3.2 billion yuan, and Fosun Pharmaceuticals hit the limit of decline

  2022-09-06 23:25

• Fosun Pharmaceuticals' profits declined: its holding of US stocks shrank significantly

  2022-08-30 18:19

• New Crown kits sold well in the United States, and Jiu'an Medical's profit exceeded 15.2 billion yuan

  2022-08-29 22:48

• The demand for new coronal vaccine decreased, and the half year net profit of Concinor fell by 99%

  2022-08-29 11:01

• Fosun "Fubitai" Vaccine Backyard Fires: Infringement Lawsuit in the United States

  2022-08-28 10:30

• Intensive collection of insulin hit Gan Li pharmaceutical industry hard, with a loss of more than 200 million yuan for the first time in three years after listing

  2022-08-25 22:23

• BGI's mid report performance declined in an all-round way, and the overseas market shrank significantly

  2022-08-25 11:19

• The Shanghai Stock Exchange of China Securities Regulatory Bureau "hit repeatedly", and Tongce Medical Group exposed three violations

  2022-08-23 14:02

• Hengrui Pharmaceutical's performance declines: it is said that it has suffered from the impact of centralized purchase

  2022-08-19 20:53

• Follow up to Deloitte's internal report: warning letter for WuXi AppTec's annual report audit

  2022-08-17 18:13

• Personnel shock of Aoyuan Meigu: the CEO with 16 years of medical and aesthetic experience resigned

  2022-08-16 10:45

• Two people died! Safety accident of major subsidiary of Hailier Pharmaceutical

  2022-08-15 11:28

• An accident occurred immediately after the first construction, 43 people were admitted to Ogilvy Med and one died

  2022-08-05 10:51

No more